InsiderPulse
Dashboard

RMD

ResMed Inc.

Health CareS&P 500

ResMed Inc. insider trading

ResMed Inc. files with the SEC as a Surgical & Medical Instruments & Apparatus company headquartered in San Diego, CA. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.

From SEC filings

Recent RMD insider transactions

3 insiders traded RMD on the open market between Mar 02, 2026 and Sep 08, 2026 — 13 sales worth $11.1M, of which every one was pre-scheduled under a 10b5-1 plan.

Bought
—
Sold
$11.1M

13 of 13 on a 10b5-1 plan

Net
−$11.1M
Insiders
3

Open-market purchases (code P) and sales (code S) from ResMed Inc.'s own SEC Form 4 filings. Grants and option exercises are excluded — they are compensation, not decisions. Share counts are derived from the reported value and price. Verify any figure against the original filing before acting on it; this is monitoring, not advice.

Filing history last read from EDGAR on Sep 18, 2026. The live dashboard shows new filings the moment they clear.

Every RMD Form 4 on SEC.gov

SEC Form 4 data, Q3 2024 to Q2 2026

RMD insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 8 insiders traded RMD on the open market: 0 purchases and 91 sales worth $85.7M, 87 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 38 sales ($29.2M), by 6 insiders.

QuarterBoughtSold
Q2 2026—−$3.8M5 sales · all on a plan
Q1 2026—−$6.2M11 sales · all on a plan
Q4 2025—−$9M12 sales · all on a plan
Q3 2025—−$10.2M10 sales · 9 on a plan
Q2 2025—−$8.9M12 sales · all on a plan
Q1 2025—−$10.4M16 sales · all on a plan
Q4 2024—−$12.5M14 sales · 12 on a plan
Q3 2024—−$24.8M11 sales · 10 on a plan
Largest sale
−$10.4M of RMD by Leong Justin (President, Asia Latin America) on Aug 05, 2024.

Open-market transactions through Jun 30, 2026most recent first

  • Farrell Michael J.10b5-1

    Chairman and CEO · Director

    −$968.1K

    Jun 08, 2026

    4,991 sh · $193.96

  • Farrell Michael J.10b5-1

    Chairman and CEO · Director

    −$1M

    May 07, 2026

    4,991 sh · $207.82

  • Farrell Michael J.10b5-1

    Chairman and CEO · Director

    −$1.1M

    Apr 07, 2026

    4,991 sh · $225.50

  • Farrell Michael J.10b5-1

    Chairman and CEO · Director

    −$1.3M

    Mar 09, 2026

    4,991 sh · $251.03

  • Farrell Michael J.10b5-1

    Chairman and CEO · Director

    −$1.4M

    Feb 09, 2026

    4,991 sh · $273.78

  • Farrell Peter C10b5-1

    Director

    −$502.6K

    Feb 04, 2026

    2,000 sh · $251.31

  • Rider Michael J10b5-1

    Global General Counsel

    −$13K

    Feb 04, 2026

    50 sh · $260.00

  • Sandercock Brett10b5-1

    Chief Financial Officer

    −$257K

    Feb 02, 2026

    1,000 sh · $257.03

  • Farrell Michael J.10b5-1

    Chairman and CEO · Director

    −$1.2M

    Jan 07, 2026

    4,991 sh · $248.46

  • Farrell Peter C10b5-1

    Director

    −$497.7K

    Jan 07, 2026

    2,000 sh · $248.83

  • Sandercock Brett10b5-1

    Chief Financial Officer

    −$241.8K

    Jan 02, 2026

    1,000 sh · $241.75

  • Rider Michael J10b5-1

    Global General Counsel

    −$12.1K

    Jan 02, 2026

    50 sh · $241.75

  • Farrell Michael J.10b5-1

    Chairman and CEO · Director

    −$1.3M

    Dec 08, 2025

    4,991 sh · $251.41

  • Farrell Peter C10b5-1

    Director

    −$502.9K

    Dec 03, 2025

    2,000 sh · $251.47

  • Sandercock Brett10b5-1

    Chief Financial Officer

    −$244.2K

    Dec 01, 2025

    1,000 sh · $244.16

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

ResMed Inc. company record

SEC industry classification
Surgical & Medical Instruments & Apparatus
Headquarters
San Diego, CA
Incorporated in
DE
Listed on
NYSE · OTC
SEC Central Index Key
0000943819

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

After insiders bought RMD

What the stock actually did in the 90 days following each open-market purchase

Don't check RMD — let it ping you

Get told the moment an insider moves on RMD

Pro watches ResMed Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add RMD to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.

Track RMD on the live dashboardFilings on SEC.gov

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

How to read RMD insider activity

Open-market purchase (code P)
An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
Grants and option exercises (codes A, M)
Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
Cluster buy
Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Other Health Care tickers

DXCMALGNEWBAXZBHHOLXVTRSMCKCORPODDNBIXSRPT
This week on the tape: who actually chose to sellThe weekly split of scheduled 10b5-1 selling vs deliberate sales, with the deciders named.

Questions

Are RMD insiders buying or selling?
Between Mar 02, 2026 and Sep 08, 2026, 3 ResMed Inc. insiders made no open-market purchases and 13 sales worth $11.1M, a net sale of $11.1M. 13 of the sales were pre-scheduled under a Rule 10b5-1 plan.
How much RMD stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 8 ResMed Inc. insiders made no open-market purchases and 91 sales worth $85.7M. 87 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 38 sales ($29.2M). The largest sale was Leong Justin selling $10.4M on Aug 05, 2024.
What was the largest recent RMD insider trade?
Farrell Peter C (Director) sold $1.8M of RMD stock on Aug 05, 2026 at about $225.00 a share, under a pre-scheduled 10b5-1 plan.
When did an insider last buy RMD shares?
No open-market purchase by a ResMed Inc. insider appears in the filings from Mar 02, 2026 to Sep 08, 2026 — every recorded open-market transaction in that period was a sale.
Where does RMD insider trading data come from?
From the Form 4 filings ResMed Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.